Regxia is a unique regulatory and e-publishing consulting firm serving the pharmaceutical and biotech industries.
For 17 years, we have acted as an extension of our clients' RA and QA operations, conducing promotional and medical materials reviews, NDA/NDS & IND/CTA preparation, eCTD publishing; XML PM publishing for Canada; CMC; medical writing; and Canadian QA and PV activities.
Services: FDA, Health Canada, - Dossier & eCTD (compilation-management-publishing); CTAs-IND, NDA, ANDA, etc.; Promotional and Medical Reviews; XML PM; surrogate Canadian QA department and PV support.